ABCC8 gene

The ABCC8 gene, also known as the ATP-binding cassette sub-family C member 8 gene, is involved in the regulation of blood glucose levels. It is primarily associated with two conditions: maturity-onset diabetes of the young and congenital hyperinsulinism. This gene provides instructions for making a protein called the sulfonylurea receptor 1 (SUR1), which is part of a complex that helps control insulin release from pancreatic beta cells.

ABCC8 gene mutations can lead to changes in the function of the SUR1 protein, resulting in abnormal insulin secretion. In some cases, these mutations can cause permanent neonatal diabetes or transient neonatal hypoglycemia. It has been found that mutations in the ABCC8 gene are responsible for a significant proportion of cases of congenital hyperinsulinism.

Scientific resources such as PubMed and OMIM, as well as genetic databases and health registries, catalog information on the ABCC8 gene and related disorders. Genetic tests can be performed to determine if an individual has mutations in this gene, which can help in the diagnosis and management of these conditions.

Further research and studies are ongoing to understand the role of the ABCC8 gene and its variants in other diseases and conditions. Additional information and resources can be found in scientific articles, clinical guidelines, and references cited in various databases.

Health Conditions Related to Genetic Changes

Genetic changes in the ABCC8 gene can lead to various health conditions. ABCC8 encodes the protein called sulfonylurea receptor 1 (SUR1), which is an essential member of the ATP-sensitive potassium (K_ATP) channels in the pancreatic beta-cells. These channels help regulate insulin secretion and play a crucial role in maintaining normal blood glucose levels.

One of the health conditions related to genetic changes in the ABCC8 gene is neonatal hyperinsulinism (HI). This congenital disorder is characterized by persistent and severe hypoglycemia (low blood sugar levels) in neonates and young infants. Genetic changes in ABCC8 can cause dysfunction in the K_ATP channels, leading to excess insulin secretion and interference with normal blood glucose control.

Additionally, genetic changes in the ABCC8 gene can also cause permanent neonatal diabetes mellitus (NDM). This form of diabetes usually presents in the first six months of life and is caused by a failure of the pancreatic beta-cells to produce enough insulin. Testing for genetic changes in ABCC8 and the related gene KCNJ11 is essential in diagnosing and managing NDM.

There are several resources available for health professionals and individuals seeking information and testing for ABCC8 gene-related conditions. The Online Mendelian Inheritance in Man (OMIM) database provides comprehensive information on genetic conditions, including neonatal hyperinsulinism and neonatal diabetes mellitus, associated with ABCC8 and KCNJ11 gene changes. ClinVar and PubMed databases also have articles and references on ABCC8 and related genes.

The Genetic Testing Registry (GTR) is another valuable resource that provides information about available genetic tests for ABCC8 gene-related conditions. It catalogues testing laboratories, the specific genes being tested, and associated health conditions. Additionally, organizations like the Genetic and Rare Diseases Information Center (GARD) and the National Organization for Rare Disorders (NORD) offer resources and support for individuals and families affected by these genetic changes.

In summary, genetic changes in the ABCC8 gene can result in health conditions such as neonatal hyperinsulinism and neonatal diabetes mellitus. Understanding these genetic changes can provide valuable information for diagnosis, management, and genetic counseling. Various databases, articles, and testing resources are available to aid in the identification and treatment of these conditions.

Congenital hyperinsulinism

Congenital hyperinsulinism is a condition caused by mutations in the ABCC8 gene, encoding the ATP-sensitive potassium (KATP) channel subunit. This gene helps control the function of beta-cell channels in the pancreas, which regulate the release of insulin.

Neonatal hypoglycemia is a common symptom of congenital hyperinsulinism, characterized by abnormally low blood sugar levels in newborns. This can lead to serious health complications if not properly managed.

The ABCC8 gene is associated with both transient and permanent forms of hyperinsulinism. In the transient form, which usually resolves by early childhood, the excess insulin secretion is temporary. In the permanent form, the condition persists throughout life and requires ongoing medical management.

There are several resources available for more information on this condition. OMIM and PubMed are scientific databases that provide additional articles and references related to congenital hyperinsulinism. The ABCC8 gene is also listed on the genetic testing catalog ClinVar, which offers testing options and information on related disorders.

The Congenital Hyperinsulinism International (CHI) registry is a valuable resource for patients and healthcare professionals. It provides a central repository of information on patients with congenital hyperinsulinism, helping to shield them from undue risks and providing support and guidance.

Genetic testing is crucial for the diagnosis and management of congenital hyperinsulinism. Testing for mutations in the ABCC8 and KCNJ11 genes is recommended in patients with suspected hyperinsulinism. These tests can help confirm the diagnosis and guide treatment decisions.

In some cases, the presence of ABCC8 gene mutations may also interfere with the function of other proteins and receptors involved in glucose regulation, leading to diabetes mellitus and other related conditions.

Overall, understanding the role of the ABCC8 gene in congenital hyperinsulinism is essential for proper diagnosis, treatment, and management of this condition.

Permanent neonatal diabetes mellitus

Permanent neonatal diabetes mellitus (PNDM) is a genetic disorder caused by variations in the ABCC8 and KCNJ11 genes. PNDM is characterized by hyperglycemia (high blood sugar levels) that develops within the first few months of life and requires lifelong management.

ABCC8 and KCNJ11 genes encode proteins that are part of the ATP-sensitive potassium (KATP) channel in pancreatic beta cells. These channels help regulate insulin secretion and maintain the normal function of beta cells. Variants in these genes can interfere with the function of KATP channels, leading to reduced insulin secretion and the development of neonatal diabetes.

Testing for the ABCC8 and KCNJ11 genes is available to confirm a diagnosis of PNDM. Genetic testing can help identify the specific variant causing the condition and provide important information for treatment and management strategies.

Children with PNDM often require insulin therapy to control their blood sugar levels. However, some cases of PNDM caused by specific variants in the ABCC8 or KCNJ11 genes can be treated with sulfonylurea drugs that help restore the function of KATP channels. Genetic testing is crucial to identify individuals who may benefit from these alternative treatments.

PNDM is a rare condition, with an estimated prevalence of around 1 in 200,000 births. It can occur as an isolated disorder or as part of other genetic syndromes and congenital disorders. The majority of PNDM cases are not associated with any other clinical features.

Patients with PNDM are at increased risk of hypoglycemia (low blood sugar) and must maintain a strict glucose monitoring and management regimen. Regular follow-up appointments and testing are necessary to ensure optimal glycemic control and prevent complications associated with diabetes.

Additional scientific information on PNDM can be found in various genetic databases, such as OMIM and the KCNJ11 and ABCC8 channels genes page. PubMed also provides a catalog of scientific articles and research on PNDM and related topics.

References:

1. Harries, L.W. et al. (2006). Permanent neonatal diabetes mellitus: insights from recent genetic discoveries. Seminar in Neonatology, 11(3), 177-183.
2. Flanagan, S.E. et al. (2007). Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11 gene) and sulfonylurea receptor 1 (ABCC8 gene) in diabetes mellitus and hyperinsulinism. Human Mutation, 28(9), 839-853.

Maturity-onset diabetes of the young

Maturity-onset diabetes of the young (MODY) is a genetic form of diabetes mellitus characterized by high blood sugar levels caused by changes in certain genes. It is different from other types of diabetes, such as type 1 and type 2 diabetes, as it typically develops in young individuals and is often inherited in an autosomal dominant manner.

The ABCC8 gene is one of the genes associated with MODY. This gene encodes a protein called SUR1, which is part of a complex that forms potassium channels in beta cells of the pancreas. These channels play a crucial role in regulating insulin secretion. Variants in the ABCC8 gene can disrupt the function of these channels, leading to impaired insulin secretion and subsequent high blood sugar levels.

Studies have shown that individuals with MODY caused by ABCC8 gene variants may respond well to treatment with sulfonylurea drugs, which act on the same potassium channels. Sulfonylurea treatment helps to control blood sugar levels by stimulating insulin secretion.

MODY is a rare form of diabetes, and an additional challenge is that different variants in the ABCC8 gene can cause different clinical manifestations. A registry called the International Society for Pediatric and Adolescent Diabetes (ISPAD) MODY registry helps to catalog genetic variants associated with MODY and their clinical presentations.

In addition to ABCC8, there are several other genes that have been associated with MODY, including HNF1A, HNF4A, and GCK. Genetic testing can be used to identify these gene variants and confirm a diagnosis of MODY.

MODY is often misdiagnosed as either type 1 or type 2 diabetes, as its symptoms can overlap with these conditions. However, proper diagnosis is important for determining the most suitable treatment approach. Unlike type 1 diabetes, which requires insulin injections, individuals with MODY caused by specific gene variants may respond well to sulfonylurea treatment.

It is important to note that MODY is not the only genetic disorder associated with the ABCC8 gene. Variants in this gene can also cause hyperinsulinism, a condition characterized by high levels of insulin in the bloodstream. Hyperinsulinism can be transient or permanent and may present in neonatal or infancy periods. It is crucial to distinguish between MODY and hyperinsulinism, as treatment approaches for these conditions differ.

For more information on MODY and related disorders, the Online Mendelian Inheritance in Man (OMIM) database and the Human Gene Mutation Database (HGMD) provide comprehensive resources. These databases list genetic variants, associated diseases, and published articles for further reading.

In summary, MODY is a rare form of diabetes caused by genetic variants in specific genes, including the ABCC8 gene. It is distinct from other types of diabetes and often presents in young individuals. Genetic testing is crucial for diagnosis, as it helps identify the specific gene variant and guide treatment approaches. Proper management of MODY can help individuals maintain better control of their blood sugar levels and overall health.

Other disorders

The ABCC8 gene is associated with a variety of other disorders, particularly those related to the regulation of blood sugar levels. Mutations in this gene can cause several different conditions, including:

• Maturity-onset diabetes of the young (MODY)
• Neonatal diabetes mellitus
• Permanent neonatal diabetes (PND)
• Hyperinsulinism of infancy (including both focal and diffuse forms)
• Congenital hyperinsulinism (CHI)

These disorders are all characterized by abnormal insulin production or function, which can lead to either low or high blood sugar levels. In some cases, mutations in the ABCC8 gene can interfere with the function of the protein it encodes, resulting in overactive insulin secretion and hypoglycemia. In other cases, the gene mutations can cause a decrease in insulin production or impair its function, resulting in hyperglycemia and diabetes.

Additional genes, such as KCNJ11, are also involved in these disorders, as they encode proteins that work together with ABCC8 to control insulin release. The specific genetic changes responsible for each condition can vary, and genetic testing can help to identify the underlying cause in affected individuals.

For more information on these disorders and the ABCC8 gene, please refer to the following resources:

• OMIM database: ABCC8
• GeneReviews: ABCC8-Related Hyperinsulinism
• PubMed articles: ABCC8 gene
• ClinGen gene curation: ABCC8
• OPG/KATP registry: Kir6.2 channelopathies registry

In conclusion, the ABCC8 gene is a member of the ATP-sensitive potassium (KATP) channel gene family and plays a critical role in the regulation of insulin secretion. Mutations in this gene can result in a variety of disorders, including MODY, neonatal diabetes mellitus, and hyperinsulinism. Understanding the genetic basis of these disorders helps in their diagnosis, treatment, and management.

Other Names for This Gene

The ABCC8 gene, also known as the sulfonylurea receptor 1 (SUR1) gene, is listed by various resources under different names. These include:

• KCNJ11
• ATP-sensitive inward rectifier potassium channel 11
• ATP-binding cassette, subfamily C, member 8
• sulfonylurea receptor beta cell
• hyperinsulinism, familial, 1
• HI
• hyperinsulinemic hypoglycemia, familial, 1
• hyperinsulinism due to SUR1 deficiency
• congenital hyperinsulinism autosomal recessive
• maturity-onset diabetes of the young 13

The ABCC8 gene encodes the SUR1 protein, which is responsible for regulating ion channels in pancreatic beta cells. These ion channels play a crucial role in the release of insulin, and mutations or changes in the ABCC8 gene can interfere with this process, leading to various conditions such as hyperinsulinism and diabetes mellitus.

Scientific studies and clinical tests have been conducted to understand the function and role of the ABCC8 gene in these diseases. The gene, along with its various names, is referenced in databases such as PubMed and ClinVar, providing valuable information for researchers and healthcare professionals.

Further reading and resources:

• Harries LW et al. (2006). A role for the ATP-binding cassette transporter gene ABCG1 in type 2 diabetes susceptibility. Genetic Testing and Molecular Biomarkers, 10(4), 316-326.
• Shields BM et al. (2010). The development and testing of a genetic risk score incorporating common genetic variants associated with type 2 diabetes. PLoS One, 5(10), e13428.
• Flannick J et al. (2014). Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nature Genetics, 46(4), 357-363.

These articles provide additional citation and references to studies and research related to the ABCC8 gene and its role in diabetes and other conditions.

For more information on genetic testing for ABCC8 gene variants and related conditions, consult your healthcare provider or genetic counseling services.

Reference:

Database	URL
PubMed	https://www.ncbi.nlm.nih.gov/pubmed/
ClinVar	https://www.ncbi.nlm.nih.gov/clinvar/
Genetic Testing Registry	https://www.ncbi.nlm.nih.gov/gtr/
OMIM	https://www.omim.org/

These resources provide databases and health information related to the ABCC8 gene and other genetic conditions.

Additional Information Resources

Here is a list of additional resources that provide more information on the ABCC8 gene:

• OMIM: The Online Mendelian Inheritance in Man (OMIM) database provides detailed information on the ABCC8 gene, including its variant names, associated disorders, and function. You can access the OMIM database for ABCC8 gene here.

• PubMed: PubMed is a search engine for scientific articles. You can find publications related to the ABCC8 gene by searching for it in the PubMed database. PubMed provides up-to-date research articles and reviews on topics related to ABCC8 gene. You can access PubMed here.

• Genetic Testing Registry: The Genetic Testing Registry provides information on genetic tests for ABCC8 gene. You can find information on which tests are available, how they are performed, and their clinical validity. The registry also provides information on laboratories offering genetic testing services. You can access the Genetic Testing Registry for ABCC8 gene here.

• Other Databases: There are other databases that also provide information on the ABCC8 gene, such as ClinVar, which catalogs genetic variants and their clinical significance, and the Human Gene Mutation Database, which collects information on disease-causing mutations in genes. These databases can be useful for finding additional information on ABCC8 gene.

• Articles: Several articles have been published on the ABCC8 gene and its role in diseases such as neonatal diabetes mellitus and congenital hyperinsulinism. Some notable articles include “The ABCC8 Gene and Sulfonylurea-Induced Hyperinsulinemic Hypoglycemia” by Ashcroft et al. and “Role of ABCC8 and KCNJ11 Genes in Congenital Hyperinsulinism: Molecular and Clinical Aspects” by Harries et al. These articles provide in-depth information on the ABCC8 gene and its function.

• References: For a comprehensive list of references and citations related to the ABCC8 gene, you can refer to the publications mentioned above and explore their reference lists. These references provide additional sources of information on the ABCC8 gene and its role in various conditions.

Tests Listed in the Genetic Testing Registry

The ABCC8 gene is associated with various disorders and plays a crucial role in the function of pancreatic beta-cell ATP-sensitive potassium (KATP) channels. Changes in this gene can interfere with the normal control of insulin and glucose levels, leading to conditions such as hyperinsulinism, transient and permanent neonatal diabetes mellitus, and congenital hyperinsulinism. The ABCC8 gene is a member of the large sulfonylurea receptor (SUR) gene family, along with another gene called KCNJ11.

Genetic testing for ABCC8 gene variants helps in the diagnosis and management of these related disorders. The Genetic Testing Registry provides a comprehensive list of tests related to this gene, along with additional resources, references, and databases for more information. These tests are essential for identifying specific variants or changes in the ABCC8 gene that may be the cause behind the observed conditions or symptoms.

Some of the tests listed in the Genetic Testing Registry for the ABCC8 gene include:

• ABCC8-related diseases panel – This panel test examines multiple genes, including ABCC8, to identify variants and changes associated with congenital hyperinsulinism, transient neonatal diabetes mellitus, and other related disorders.
• ABCC8 gene sequencing – This test focuses specifically on sequencing the ABCC8 gene to identify any changes in the genetic code that may be responsible for the observed conditions.
• ABCC8 gene deletion/duplication analysis – This test aims to detect large deletions or duplications in the ABCC8 gene that may result in a loss or gain of function.

Genetic testing for the ABCC8 gene can help healthcare professionals in making accurate diagnoses, providing appropriate treatment plans, and offering genetic counseling and guidance for affected individuals and their families.

References and citations for these tests can be found on the Genetic Testing Registry, as well as in scientific databases such as PubMed, OMIM, and the Clinical Catalog of Genes and Diseases (ClinGen). These resources provide comprehensive information on the ABCC8 gene, its function, related conditions, and other genes involved in the process.

In summary, the ABCC8 gene plays a crucial role in the function of pancreatic beta-cell ATP-sensitive potassium (KATP) channels, and changes in this gene can lead to various disorders related to insulin and glucose control. Genetic testing listed in the Genetic Testing Registry helps in identifying specific variants or changes in the ABCC8 gene, providing valuable information for the diagnosis and management of related conditions.

Scientific Articles on PubMed

The ABCC8 gene, also known as the sulfonylurea receptor 1 (SUR1) gene, is a member of the ATP-binding cassette (ABC) transporter gene family. It is primarily expressed in the pancreatic beta-cell and plays a crucial role in the regulation of insulin secretion and glucose homeostasis.

Mutations in the ABCC8 gene can cause congenital hyperinsulinism (CHI), a condition characterized by excessive insulin production and low blood sugar levels. This gene encodes the SUR1 subunit of the ATP-sensitive potassium (KATP) channels, which are responsible for regulating insulin release from the beta-cells.

Scientific articles on PubMed provide valuable information regarding the role of ABCC8 gene mutations in various disorders and conditions. These articles help in understanding the normal function of the protein encoded by this gene and how changes or disruptions in its function can lead to different diseases.

In the context of ABCC8 gene, PubMed offers a comprehensive catalog of scientific articles related to neonatal diabetes mellitus, maturity-onset diabetes of the young (MODY), and other related conditions. The articles listed in PubMed include references to genetic testing, receptor function, and additional studies on related genes and health issues.

PubMed also provides access to OMIM (Online Mendelian Inheritance in Man) database, which contains detailed information on the ABCC8 gene and related diseases. The database includes citations from scientific articles, genetic testing resources, and other relevant information.

Some of the scientific articles available on PubMed include:

• “Genetic testing for neonatal diabetes mellitus: a curated registry of the ABCC8 and KCNJ11 genes” by Shield, J.P.H. et al.
• “Sulfonylurea receptor 1 mutations and therapeutic response in congenital hyperinsulinism” by Thomas, P.M. et al.
• “Congenital hyperinsulinism: clinical and molecular analysis of the KCNJ11 gene in Italian patients” by Harries, L.W. et al.

These articles provide valuable insights into the phenotype and genotype of individuals with ABCC8 gene mutations, the implications for treatment options, and the potential long-term outcomes for those affected by these conditions.

Catalog of Genes and Diseases from OMIM

The ABCC8 gene is a scientific catalog of genes and diseases from OMIM, a database that provides information on the genetic basis of various disorders. This catalog lists the sulfonylurea receptor 1 (ABCC8) gene, which is implicated in several diseases and conditions.

One of the main diseases associated with mutations in the ABCC8 gene is neonatal diabetes mellitus, a rare form of diabetes that occurs in the first months of life. ABCC8 gene mutations can also cause transient neonatal hyperinsulinism, a condition characterized by excessive insulin production by the pancreatic beta cells.

The ABCC8 gene encodes the sulfonylurea receptor, a protein that helps regulate the function of potassium channels (KATP channels) in the pancreatic beta cells. These channels play a central role in the control of insulin secretion. Mutations in the ABCC8 gene can interfere with the normal function of these channels, leading to abnormal insulin release and glucose regulation.

Testing for variants in the ABCC8 gene is available and can be used to diagnose or confirm the presence of related disorders. Genetic testing can also be used for carrier testing, prenatal testing, and testing of other family members.

OMIM provides a comprehensive catalog of genes and diseases, with references to scientific articles and other resources. The catalog includes names and citations of related articles, as well as links to additional resources and databases.

OMIM also offers a registry of genetic tests for various diseases and conditions, including those related to the ABCC8 gene. This registry provides information on the available tests, their indications, and their limitations.

In addition to neonatal diabetes mellitus and transient neonatal hyperinsulinism, mutations in the ABCC8 gene have been linked to other conditions such as congenital hyperinsulinism and maturity-onset diabetes of the young (MODY).

Overall, the ABCC8 gene is an important genetic factor in the development of various diseases and disorders related to insulin secretion and glucose regulation. The catalog from OMIM provides a valuable resource for researchers, healthcare professionals, and individuals interested in the genetic basis of these conditions.

Gene and Variant Databases

The ABCC8 gene, also known as the sulfonylurea receptor 1 (SUR1) encoding member of the ATP-binding cassette (ABC) protein family, plays a crucial role in the control of insulin secretion by pancreatic beta-cells. Variants in this gene can cause various diseases, including neonatal diabetes, permanent neonatal diabetes mellitus (PNDM), transient neonatal diabetes mellitus (TNDM), and hyperinsulinism, both focal and diffuse forms.

The ABCC8 gene is listed in various gene and variant databases, which provide additional resources and information related to its function and associated disorders. These databases include the Online Mendelian Inheritance in Man (OMIM), PubMed, and other scientific catalogs.

The following databases are useful for genetic testing and research on ABCC8 gene variants:

• OMIM: OMIM is a comprehensive database that contains information on various genetic disorders and genes. It provides detailed descriptions, references to relevant articles, and the available genetic tests for different conditions.
• PubMed: PubMed is a database of scientific articles and publications. It contains a vast collection of research papers on genetics, including studies on ABCC8 gene variants and related conditions.
• Genetic Testing Registry: This registry provides information about genetic tests available for specific genes and conditions. It includes details on the types of tests, laboratories offering the tests, and their clinical utility.
• Human Gene Mutation Database (HGMD): HGMD is a database that catalogs mutations and variants in human genes. It offers curated information on DNA sequence changes and their associated phenotypes.
• HARRe Diabetes Registry: The Hyperinsulinism and Adenylosuccinate Lyase Related Disorders (HARRe) Diabetes Registry is a specialized resource for patients with hyperinsulinism and related disorders. It provides information on diagnosis, testing, and treatment options.

These databases and resources help researchers, clinicians, and individuals seeking information on ABCC8 gene variants and related conditions to stay updated with the latest findings and developments. They provide a comprehensive platform for accessing scientific literature, testing options, and expert opinions in the field of genetic research.

References

1. PubMed: Listed below are some articles related to the ABCC8 gene:

   • Clinical and genetic characterization of 38 children with congenital hyperinsulinism caused by mutations in the ABCC8 encoding SUR1. (PubMed ID: 12384504)
   • Association of ABCC8 R1380H gene variation with newborn screening for congenital hyperinsulinism in the Jewish population. (PubMed ID: 15994890)
   • Additional mutations in the ABCC8 gene and evidence for genetic heterogeneity in persistent hyperinsulinemic hypoglycemia of infancy. (PubMed ID: 16300918)

2. OMIM: The Online Mendelian Inheritance in Man (OMIM) provides information on various genetic disorders. You can refer to the following articles for more information on ABCC8 gene:

   • ABCC8 gene – Maturity-onset Diabetes of the Young, Type 9 (MODY9) (OMIM ID: 600496)
   • ABCC8 gene – Congenital Hyperinsulinism, Autosomal Dominant 2 (OMIM ID: 601410)
   • ABCC8 gene – Hyperinsulinemic Hypoglycemia, Familial, 1 (OMIM ID: 256450)

3. ClinVar: ClinVar is a freely accessible database that provides information about genetic variants and their relationship to diseases. You can find more information on ABCC8 gene variants related to various disorders on ClinVar website.

4. Testing Resources: The following resources provide genetic testing for ABCC8 gene-related disorders:

   • Genetic Testing Registry (GTR) – ABCC8 gene
   • GeneTests – ABCC8

5. The KCNJ11 Gene: The KCNJ11 gene, encoding the Kir6.2 subunit of the KATP channel, is closely related to the ABCC8 gene. Variants in the KCNJ11 gene can also lead to hyperinsulinism. For more information, you can refer to the following resources:

   • Harries et al. (2009) – The influence of type 2 diabetes-associated variants in KCNJ11 on glucose metabolism during pregnancy. (PubMed ID: 19487812)
   • KCNJ11 – Potassium Inwardly-Rectifying Channel, Subfamily J, Member 11 (OMIM ID: 600937)

6. Other related genes: In addition to ABCC8 and KCNJ11 genes, there are other genes and ion channels involved in pancreatic beta-cell function. Some of these genes include:

   • INS – Insulin (OMIM ID: 176730)
   • GPCR – G Protein-Coupled Receptor (OMIM ID: 600297)
   • GLUT2 – Glucose Transporter 2 (OMIM ID: 138160)
   • PDX1 – Pancreatic and Duodenal Homeobox 1 (OMIM ID: 600733)

7. Health Conditions and Diseases: ABCC8 gene mutations and related disorders are associated with various health conditions and diseases, including:

   • Hyperinsulinism
   • Neonatal diabetes mellitus
   • Maturity-Onset Diabetes of the Young (MODY)
   • Central Diabetes Insipidus

8. Citation: Information in this section regarding various scientific articles, databases, and resources has been compiled from multiple sources including PubMed, OMIM, ClinVar, and GTR.